The global market for brain monitoring devices was valued at $1.08 billion in 2012 and is expected to grow to $1.63 billion, up 8.6 percent, by 2017.
Multimodal monitoring of brain function is growing in many preoperative settings, largely due its increased use to assess the depths of anesthesia and sedation. North America dominated the global market in 2012, with Europe and Asia following. Experts expect North American to continue to be a leader, according to the report.
A shortage of technicians to run these devices will limit the growth of the market.
More Articles on Anesthesia:
TeamHealth Acquires Two Arizona Emergency Care Physician Groups
Partnerships Among Hospitals and Anesthesiology Practices Give Stipends a Fair Assessment
Study: Exercise May Decrease Neuropathic Pain From Diabetes
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
